KR920011514A - 프로게스토겐만을 함유하는 피임제 - Google Patents

프로게스토겐만을 함유하는 피임제 Download PDF

Info

Publication number
KR920011514A
KR920011514A KR1019910023066A KR910023066A KR920011514A KR 920011514 A KR920011514 A KR 920011514A KR 1019910023066 A KR1019910023066 A KR 1019910023066A KR 910023066 A KR910023066 A KR 910023066A KR 920011514 A KR920011514 A KR 920011514A
Authority
KR
South Korea
Prior art keywords
desogestrel
progestogen
dosage unit
daily
mixture
Prior art date
Application number
KR1019910023066A
Other languages
English (en)
Other versions
KR100221008B1 (ko
Inventor
얀 티이멘 코엘링 베닝크 헤르만
윌렘 베르깅크 엥겔베르트
Original Assignee
원본미기재
악조 엔. 브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205203&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR920011514(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 원본미기재, 악조 엔. 브이. filed Critical 원본미기재
Publication of KR920011514A publication Critical patent/KR920011514A/ko
Application granted granted Critical
Publication of KR100221008B1 publication Critical patent/KR100221008B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

내용 없음

Description

프로게스토겐만을 함유하는 피임제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 피임에 효과적인 단일성분으로서 70내지 80㎍의 데소게스트렐, 3-게토데소게스트렐, 또는 이들의 혼합물을 각각 함유하는 경구투여용 일일 연속투여 단위를 포함하는 복합피임키트.
  2. 제1항에 있어서, 상기 키트가 21 내지 35개의 상기 일일연속 투여 단위를 함유하는 복합 피임키트.
  3. 제2항에 있어서, 상기 프로게스토겐이 3-케토데소게스트렐이며 투여단위당 75㎍의 분량이 존재하는 복합피임 키트.
  4. 제2항에 있어서, 상기 프로게스토겐이 데소게스트렐이며 투여단위당 75㎍의 분량이 존재하는 복합피임키트.
  5. 피임에 효과적인 단일성분으로서 프로게스토겐 화합물만을 함유하는 일일투여단위로 구성되는 의약운반 시스템을 제조하는데, 데소게스트렐, 3-케토데소게스트렐 또는 그들의 혼합물로 이루어지는 프로게스코겐균에서 선택된 70 내지 80㎍의 프로게스토겐을 주성분으로 하는 일일경구 투여 단위를 사용하는 방법.
  6. 갱년기전의 여성에게 피임이 필요할때가지 3-게토데소게스트렐, 데소게스트렐 및 그들의 혼합물로 이루어지는 군에서 선택된 70내지 80㎍의 스테로이드를 매일 경구투여하는 것을 포함하는 갱년기전 여성의 피임방법.
  7. 데소게스트렐, 3-게토데소게스트렐 및 이들의 혼합물로 이루어지는 군에서 선택된 화합물 70내지 80㎍을 주성분으로 하는 26 내지 30개의 일일연속 투여단위를 함유하는 포장단위를 포함하는 의약운반 시스템.
  8. 프로게스토겐으로서 70내지 80㎍의 3-케토데스게스트렐, 데소게스트렐 또는 이들의 혼합물을 사용하는 것을 특징으로하는, 프로게스토겐만을 함유하는 일일투여단위로 이루어진 피임키트.
  9. 데스게스트렐, 3-게토데소케스트렐, 그들의 혼합물로 이루어지는 군에서 선택된 소정량의 프로게스토겐을 소정량의 부형제와 혼합하고 이 혼합물을 각각 70내지80㎍의 데소게스트렐, 3-게토데소게스트렐, 또는 그들의 혼합물을 함유하는 투여단위로 전환시키고, 복수개의 상기 투여단위를 키트에 포장하는 것을 포함하는 의약운반 시스템의 제조방법.
  10. 제9항에 있어서, 상기 혼합물을 캡슐 및 경제로 이루어지는 군에서 선택된 투여단위로 전환시키는 제조방법.
    ※ 참고사항：최초출원 내용에 의하여 공개하는 것임.
KR1019910023066A 1990-12-17 1991-12-16 프로게스토겐만을 함유하는 피임제 KR100221008B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90203371.1 1990-12-17
EP90203371 1990-12-17

Publications (2)

Publication Number Publication Date
KR920011514A true KR920011514A (ko) 1992-07-24
KR100221008B1 KR100221008B1 (ko) 1999-09-15

Family

ID=8205203

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910023066A KR100221008B1 (ko) 1990-12-17 1991-12-16 프로게스토겐만을 함유하는 피임제

Country Status (20)

Country Link
US (1) US5461041A (ko)
EP (1) EP0491443B1 (ko)
JP (1) JPH04290829A (ko)
KR (1) KR100221008B1 (ko)
CN (1) CN1036834C (ko)
AT (1) ATE135218T1 (ko)
AU (1) AU649082B2 (ko)
CA (1) CA2057714C (ko)
DE (2) DE19975011I2 (ko)
DK (1) DK0491443T3 (ko)
ES (1) ES2087237T3 (ko)
FI (1) FI98984C (ko)
GR (1) GR3020180T3 (ko)
IE (1) IE71202B1 (ko)
LU (1) LU90341I2 (ko)
NL (1) NL990003I2 (ko)
NO (2) NO2002013I2 (ko)
NZ (1) NZ240969A (ko)
PT (1) PT99818B (ko)
ZA (1) ZA919732B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4133680A1 (de) * 1991-10-11 1993-04-15 Metallgesellschaft Ag Stabilisierte staerke, verwendung der stabilisierten staerke und verfahren zu ihrer herstellung
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
ZA949929B (en) * 1993-12-23 1995-08-23 Akzo Nobel Nv Sugar-coated pharmaceutical dosage unit.
DE4405590C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonbehandlung
DK0782449T3 (da) * 1994-09-22 2003-08-04 Akzo Nobel Nv Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
AU4134599A (en) * 1998-04-07 1999-10-25 Akzo Nobel N.V. Progestogen-only contraceptive kit
AU5619399A (en) * 1998-08-11 2000-03-06 Akzo Nobel N.V. Progestogen-only contraceptive kit providing good cycle control
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0114746D0 (en) 2001-06-16 2001-08-08 Boots Co Plc Medicinal composition
US6574033B1 (en) 2002-02-27 2003-06-03 Iridigm Display Corporation Microelectromechanical systems device and method for fabricating same
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
DE102005053771A1 (de) * 2005-11-09 2007-05-10 Grünenthal GmbH Darreichform zur hormonalen Kontrazeption
DE202010010589U1 (de) 2010-07-22 2010-10-14 Bayer Schering Pharma Aktiengesellschaft Estrogenfreie Formulierung zur oralen Kontrazeption, bevorzugt verwendbar für Frauen mit bewusster/unbewusster Laktoseintoleranz oder mit bewusster laktosefreier Kontrazeption
EP2730284A1 (en) * 2012-11-12 2014-05-14 Naari AG Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation
WO2017000081A1 (zh) * 2015-06-30 2017-01-05 上海交通大学 Etonogestrel在制备抗***癌产品中的应用
US11679114B2 (en) 2021-07-26 2023-06-20 Navad Life Sciences Pte Progestogen-only oral contraception

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066757A (en) * 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat

Also Published As

Publication number Publication date
AU649082B2 (en) 1994-05-12
NO178686C (no) 1996-05-15
CN1036834C (zh) 1997-12-31
ZA919732B (en) 1992-09-30
US5461041A (en) 1995-10-24
DE69117902T2 (de) 1996-08-29
KR100221008B1 (ko) 1999-09-15
FI915913A (fi) 1992-06-18
FI98984B (fi) 1997-06-13
PT99818B (pt) 1999-05-31
NO178686B (no) 1996-02-05
CA2057714C (en) 2002-10-01
ATE135218T1 (de) 1996-03-15
NL990003I2 (nl) 1999-05-03
DE19975011I2 (de) 2005-05-04
EP0491443B1 (en) 1996-03-13
PT99818A (pt) 1992-11-30
FI98984C (fi) 1997-09-25
NO914970L (no) 1992-06-18
JPH04290829A (ja) 1992-10-15
GR3020180T3 (en) 1996-09-30
CN1062465A (zh) 1992-07-08
NZ240969A (en) 1994-04-27
LU90341I2 (fr) 1999-03-29
NL990003I1 (nl) 1999-04-01
IE914271A1 (en) 1992-06-17
NO2002013I2 (no) 2007-02-26
DK0491443T3 (da) 1996-06-24
DE69117902D1 (de) 1996-04-18
EP0491443A1 (en) 1992-06-24
ES2087237T3 (es) 1996-07-16
AU8967891A (en) 1992-06-18
FI915913A0 (fi) 1991-12-16
NO914970D0 (no) 1991-12-16
CA2057714A1 (en) 1992-06-18
IE71202B1 (en) 1997-02-12

Similar Documents

Publication Publication Date Title
KR920011514A (ko) 프로게스토겐만을 함유하는 피임제
KR900701277A (ko) 피임 시스템 및 방법
DE69710896T2 (de) Progestogen-anti-progestogen therapien
NL300025I1 (nl) Combinatie doseringsvorm voor vrouwen in de pre-menopauze.
RU96115196A (ru) Состав для контрацепции
IL122109A0 (en) A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same
AU1191092A (en) Ovulation-preventing agent for hormonal contraception
KR19990076685A (ko) 게스타겐 및 에스트로겐의 배합을 포함하는 암컷 포유동물용 피임 방법 및 키트
NZ307178A (en) Medicament for contraception; contains two, separately packed, sequential hormonal components
KR970706004A (ko) 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies)
MX9304931A (es) Anticonceptivos que contienen antiprogestogenos.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110610

Year of fee payment: 13

EXPY Expiration of term